Have a personal or library account? Click to login
Management of Microvascular Complications in Secondary Diabetes Associated with Autoimmune Diseases — Case Report Cover

Management of Microvascular Complications in Secondary Diabetes Associated with Autoimmune Diseases — Case Report

Open Access
|Nov 2017

References

  1. 1. Boelaert K, Newby PR, Simmonds MJ, et al. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med. 2010;123:183.e1-183. e9.10.1016/j.amjmed.2009.06.030
  2. 2. Wu JJ, Rowan CG, Bebchuk JD, Anthony MS. No Association Between TNF Inhibitor and Methotrexate Therapy Versus Methotrexate in Changes in Hemoglobin A1C and Fasting Glucose Among Psoriasis, Psoriatic Arthritis, and Rheumatoid Arthritis Patients. J Drugs Dermatol. 2015;14:159-166.
  3. 3. Liu D, Ahmet A, Ward L, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 2013;9:30.10.1186/1710-1492-9-30
  4. 4. Aspden RM. Obesity punches above its weight in osteoarthritis. Nat Rev Rheumatol. 2011;7:65-68.10.1038/nrrheum.2010.123
  5. 5. Wang H, Wang PB, Chen T, et al. Analysis of clinical characteristics of immune-related dry eye. J Ophthalmol. 2017;2017:8532397.10.1155/2017/8532397
  6. 6. Abbouda A, Abicca I, Fabiani C, et al. Psoriasis and psoriatic arthritisrelated uveitis: different ophthalmological manifestations and ocular inflammation features. Semin Ophthalmol. 2016;15:1-6.
  7. 7. Yen YC, Weng SF, Lai FJ, Lin YS. Risk of retinal vein occlusion in patients with psoriasis: A population-based cohort study. Retina. 2015;35:1786-1794.10.1097/IAE.0000000000000536
  8. 8. Karch A, Thomas SL. Autoimmune thyroiditis as risk factor for stroke. Neurology. 2014;82:1643-1652.10.1212/WNL.0000000000000377
  9. 9. Mallbris L, Ritchlin CT, Stahle M. Metabolic disorders in patients with psoriasis and psoriatic arthritis. Curr Rheumatol Rep. 2006;8:355-363.10.1007/s11926-006-0065-8
  10. 10. Szekanecz Z, Koch AE. Vascular involvement in rheumatic diseases: ‘vascular rheumathology’. Arthriris Res Ther. 2008;10:224.10.1186/ar2515
  11. 11. Lentz SR. Homocysteine and vascular dysfunction. Life Sci. 1997;61:1205-1215.10.1016/S0024-3205(97)00392-5
  12. 12. Vu TT, Fredenburgh JC, Weitz JI. Zinc: an important cofactor in haemostasis and thrombosis. Thromb Haemost. 2013;109:421-430.10.1160/TH12-07-046523306381
  13. 13. Tlili N, Elfalleh W, Saadaoui E, Khaldi A, Triki S, Nasri N. The caper (Capparis L.): Ethnopharmacology, phytochemical and pharmacological properties. Fitoterapia. 2011;82:93-101.10.1016/j.fitote.2010.09.00620851750
DOI: https://doi.org/10.1515/jim-2017-0071 | Journal eISSN: 2501-8132 | Journal ISSN: 2501-5974
Language: English
Page range: 270 - 274
Submitted on: Aug 7, 2017
Accepted on: Aug 21, 2017
Published on: Nov 8, 2017
Published by: Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2017 Enikő Nemes-Nagy, Robert Gabriel Tripon, Sándor Pál, Mariana Cornelia Tilinca, published by Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.